Navigation Links
Six-Minute Surgical Instrument Sterilizer to Protect Patients and Save Hospitals $Billions
Date:4/14/2009

DOVER, N.J., April 14 /PRNewswire/ -- Germgard Lighting LLC, a New Jersey based, early phase medical technology company, has demonstrated its patented, ultra-fast surgical instrument resterilization system. Germgard's technology will protect millions of patients and lower the overall cost of care by preventing infections resulting from surgery in large healthcare facilities, military field hospitals, and ambulatory surgical centers.

The total cycle time for the process is much shorter than for hot steam sterilization or any room-temperature, gas sterilant process. Shorter cycle times and room temperature are important since they reduce instrument damage and enhance inventory turnaround -- critical considerations for operational efficiency. The six-minute cycle time makes Germgard's method unique and ideal for all surgical venues.

According to Germgard's CEO, Dr. Eugene I. Gordon, "Deployment of our efficacious, easy-to-use, and ultra-fast sterilization products will be one of the least expensive, quickest to implement, and most effective means for healthcare facilities to immediately lower operating costs and properly protect patients undergoing surgery."

The ability to inactivate all pathogens, including spores, with room temperature techniques in just six minutes to achieve 100% kill was absolutely unimaginable only a couple of years ago. "This tabletop system, featuring scalable capacity, and available at autoclave price points, is truly disruptive," says Cheryl Perkins, President of Innovation Edge, an industry recognized Innovation thought leader.

Germgard is positioned to assist hospitals to run better, provide higher quality healthcare, produce improved patient outcomes and reduce costs. The Germgard solution for instrument resterilization will resolve the persistent issues of speed, efficacy, and instrument wear that have long plagued instrument resterilization in hospitals and clinics, and placed millions of patients, as well as the financial well-being of healthcare, at risk. Gordon adds, "Commercialization and implementation of this solution will positively impact infection prevention and resolve operational cost tradeoffs facing hospital CEOs."

Germgard Lighting LLC is funded by and located in a NJ Commission on Science and Technology supported innovation incubator on the campus of the U.S. Army Picatinny Arsenal. Its technology pipeline enables a multi-tiered approach to infection prevention that includes cost-effective bare and gloved hand sanitation, medical instrument sterilization, surface cleaning and air sterilization. The Company represents an excellent example of a public-private partnership creating local jobs, solving critical healthcare delivery problems, and protecting patients and consumers.

    Media Contact:

    Peter Gordon, VP of Marketing, Germgard Lighting LLC
    Phone: 973-607-1542
    FAX: 973-607-1543
    e-mail: pgordon@germgardlighting.com
    Website:http://www.germgardlighting.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Germgard Lighting LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Spectrum Surgical Instruments Announces: Quality Management System Certification
2. Study assesses new surgical procedure for regenerating cartilage in damaged knee joints
3. Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery
4. M. D. Anderson study finds pre-surgical stress management improves mood, quality of life
5. Psychotherapy Can Ease Post-Surgical Depression
6. Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
7. Nationwide Medical/Surgical Announces Availability of Tamiflu for the 2009-2010 Influenza Season
8. Surgical Care Affiliates Announces Investor Conference Call to Discuss 2008 Fourth Quarter and Year-End Results
9. New Trend Data Shows Access to Surgical Care at Risk in Rural and Urban Areas of the United States
10. Surgical Groups Form Operation Patient Access: Quality Surgical Care for All to Call Attention to Escalating Workforce Shortage
11. Endure Medical Redefines Ophthalmic Surgical Microscopes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... April 22, 2017 , ... ... as Vice President of Sales and Business Development at OAKWORKS, Inc. Mr. ... engagements, business development, and strategic planning for the company. Recognized industry-wide as ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... An April ... of a pair of ancient teeth, which reveal a great deal about prehistoric ice-age ... a sharp stone may have been used to remove decayed dental matter, and that ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to ... in the 2017 London Marathon. Set to take place on April 23rd, the London Marathon ... Dr. Schwartz will run as part of team EMPOWER, raising money for the international charity, ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Chicago plastic surgeon, ... removal of osteoma. An osteoma is a benign bony lump located on the forehead ... and can cause difficulties with sight and pain. Dr. Shah has discovered an approach ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: